Response

Affiliations

¹ Division of Rheumatology, Chicago, IL. Electronic address: nsweiss@uic.edu.
² University of Illinois at Chicago, Department of Nephrology and Rheumatology, Göttingen, Germany.
³ University Medical Center Göttingen, Department of Medicine, Cincinnati, OH.
⁴ University of Cincinnati Medical Center, Pulmonary and Critical Care Medicine, Cleveland, OH.
⁵ Cleveland Clinic, Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY.

Comment

Nadera J Sweiss et al. Chest. 2021 Mar.

. 2021 Mar;159(3):1307-1308.

doi: 10.1016/j.chest.2020.10.005.

¹ Division of Rheumatology, Chicago, IL. Electronic address: nsweiss@uic.edu.
² University of Illinois at Chicago, Department of Nephrology and Rheumatology, Göttingen, Germany.
³ University Medical Center Göttingen, Department of Medicine, Cincinnati, OH.
⁴ University of Cincinnati Medical Center, Pulmonary and Critical Care Medicine, Cleveland, OH.
⁵ Cleveland Clinic, Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY.

No abstract available

Comment on

When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic.
Sweiss NJ, Korsten P, Syed HJ, Syed A, Baughman RP, Yee AMF, Culver DA, Sosenko T, Azuma A, Bonella F, Costabel U, Drake WP, Drent M, Lower EE, Israel-Biet D, Mostard RLM, Nunes H, Rottoli P, Spagnolo P, Wells AU, Wuyts WA, Judson MA. Sweiss NJ, et al. Chest. 2020 Sep;158(3):892-895. doi: 10.1016/j.chest.2020.04.033. Epub 2020 Apr 29. Chest. 2020. PMID: 32360495 Free PMC article. No abstract available.
Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019.
Tana C, Schiavone C, Cipollone F, Giamberardino MA. Tana C, et al. Chest. 2021 Mar;159(3):1306-1307. doi: 10.1016/j.chest.2020.09.267. Chest. 2021. PMID: 33678261 Free PMC article. No abstract available.

1. Sweiss N.J., Korsten P., Syed H.J., et al. When the game changes: guidance to adjust sarcoidosis management during the coronavirus disease 2019 pandemic. Chest. 2020;158(3):892–895. - PMC - PubMed
1. Gianfrancesco M., Hyrich K.L., Al-Adely S., et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859–866. - PMC - PubMed
1. Doran M.F., Crowson C.S., Pond G.R., O’Fallon W.M., Gabriel S.E. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002;46(9):2294–2300. - PubMed
1. Singh J.A., Cameron C., Noorbaloochi S., et al. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015;386(9990):258–265. - PMC - PubMed
1. Ibrahim A., Ahmed M., Conway R., Carey J.J. Risk of infection with methotrexate therapy in inflammatory diseases: a systematic review and meta-analysis. J Clin Med. 2018;8(1):15. - PMC - PubMed